NYSE:TBITrueblue Stock Price, Forecast & News

Trueblue's stock was trading at $13.35 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TBI stock has increased by 8.4% and is now trading at $14.47. View which stocks have been most impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trueblue in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Trueblue.

Trueblue is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Trueblue.

Trueblue Inc (NYSE:TBI) announced its quarterly earnings results on Monday, May, 4th. The business services provider reported ($0.01) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.04 by $0.05. The business services provider earned $494.30 million during the quarter, compared to analysts' expectations of $495.22 million. Trueblue had a positive return on equity of 12.19% and a negative net margin of 4.14%. The business's quarterly revenue was down 10.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.27 earnings per share. View Trueblue's earnings history.

3 analysts have issued twelve-month price targets for Trueblue's shares. Their forecasts range from $15.00 to $17.00. On average, they anticipate Trueblue's share price to reach $16.00 in the next year. This suggests a possible upside of 10.6% from the stock's current price. View analysts' price targets for Trueblue.

Headlines about TBI stock have trended negative on Saturday, according to InfoTrie. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Trueblue earned a coverage optimism score of -2.0 on InfoTrie's scale. They also gave news articles about the business services provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about Trueblue.

Some companies that are related to Trueblue include Tradeweb Markets (TW), Robert Half International (RHI), ManpowerGroup (MAN), ASGN (ASGN), Insperity (NSP), Wageworks (WAGE), Korn Ferry (KFY), Kforce (KFRC), Kelly Services (KELYA), Heidrick & Struggles International (HSII), Barrett Business Services (BBSI), GP Strategies (GPX) and Hudson Global (HSON). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Trueblue investors own include IBM (IBM), Intel (INTC), NVIDIA (NVDA), AT&T (T), Vertex Pharmaceuticals (VRTX), AbbVie (ABBV), Amgen (AMGN), Gilead Sciences (GILD), Goldman Sachs Group (GS) and USANA Health Sciences (USNA).

Trueblue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

Shares of TBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of TBI stock can currently be purchased for approximately $14.47.

Trueblue has a market capitalization of $522.74 million and generates $2.37 billion in revenue each year. The business services provider earns $63.07 million in net income (profit) each year or $2.05 on an earnings per share basis. Trueblue employs 6,200 workers across the globe.

The official website for Trueblue is www.trueblue.com.

Trueblue's mailing address is 1015 A STREET, TACOMA WA, 98402. The business services provider can be reached via phone at 253-383-9101 or via email at [email protected]